Ziad Omran
Jeddah, 21423, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Disulfiram and Its Derivatives: An Immortal Phoenix of Drug Repurposing.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 18, 2025
Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy.
Journal: International journal of molecular sciences
Published: August 27, 2024
Similarity of drug targets to human microbiome metaproteome promotes pharmacological promiscuity.
Journal: The pharmacogenomics journal
Published: July 15, 2024
In Vitro and In Vivo Preventive Effects of Thymoquinone against Breast Cancer: Role of DNMT1.
Journal: Molecules (Basel, Switzerland)
Published: October 31, 2023
The Potential Role of Nigella sativa Seed Oil as Epigenetic Therapy of Cancer.
Journal: Molecules (Basel, Switzerland)
Published: March 21, 2022
Novel Disulfiram Derivatives as ALDH1a1-Selective Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: December 16, 2021
Design, Synthesis and In-Vitro Biological Evaluation of Antofine and Tylophorine Prodrugs as Hypoxia-Targeted Anticancer Agents.
Journal: Molecules (Basel, Switzerland)
Published: May 09, 2021
New Disulfiram Derivatives as MAGL-Selective Inhibitors.
Journal: Molecules (Basel, Switzerland)
Published: April 28, 2021
Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex.
Journal: Genes
Published: March 19, 2021
The pH-Induced Specific Area Changes of Unsaturated Lipids Deposited onto a Bubble Interface.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: February 12, 2021
Last Updated: 09/26/2026